Bayer AG NA (BAYGn)

50.11
-0.40(-0.79%)
  • Volume:
    2,385,448
  • Bid/Ask:
    50.11/0.00
  • Day's Range:
    49.87 - 50.67
  • Type:Equity
  • Market:Germany
  • ISIN:DE000BAY0017
  • WKN:BAY001

BAYGn Overview

Prev. Close
50.51
Day's Range
49.87-50.67
Revenue
40.88B
Open
50.54
52 wk Range
39.91-59.55
EPS
-15.11
Volume
2,385,448
Market Cap
49.62B
Dividend (Yield)
2.00
(3.98%)
Average Vol. (3m)
2,734,054
P/E Ratio
-
Beta
1.31
1-Year Change
-10.19%
Shares Outstanding
982,424,082
Next Earnings Date
Aug 05, 2021
What is your sentiment on Bayer AG NA?
or
Market is currently closed. Voting is open during market hours.

Bayer AG NA News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsBuyStrong BuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell

Bayer AG NA Company Profile

Bayer AG NA Company Profile

Employees
99329
Market
Germany

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. Bayer Aktiengesellschaft has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc. and Forschungszentrum Jülich GmbH; strategic research partnership with University of Oxford to develop novel gynecological therapies; and research collaboration agreements with Haplogen GmbH and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Read More
  • trash .
    6
    • trash
      6
      • one step before the bankruptcy . Trash stock.
        2
    • buy
      2
      • "Severe blast at Bayer chemical complex in Germany's Leverkusen"
        2
        • the currenta factory is not part of bayer.
          0
      • L'Amministratore Delegato della BAYER deve assolutamente risolvere i problemi legati al diserbante in USA senza se e senza ma per far decollare il titolo al massimo.
        0
        • long baygn
          0
          • Long Baygn,all the rating from big investment banks will be fullfil this year,price target 75-80 !
            0
            • sell BAYGn and buy VEON from Amsterdam, now the stock price is at 1.45e in end of July will be more than 2 euros.
              4
              • Lol. Nobody buys this trash
                1
              • yes is a gld trash.!-)))
                0
            • I did the same mistake, bought this trash
              3
              • Biggest regret of my trading life buying this trash company
                2
                • ..... me too....
                  1
                • Hold on and be patient, it is a stock for long runner
                  1
                • I sold for a profit at 53.4. It was on the right path, but the last court decision was scary. I will reconsider if it re-tests 40 because agriculture will be mostly written off. As the romans used to say: Werner Baumann delenda est.
                  0
              • max 51 euros not more is End Story BAYGn.
                3
                • with acquisition of Noria, should at least go the 55/56 level.
                  2
                  • 51
                    4
                    • Very difficult situation, even in resolving the cases, the company will face enormous challenges
                      1
                      • What does point 4 of the 5 point plan mean? Are they going to fight settlements instead of trying to resolve them?
                        0
                        • Any suggestion? What to do now? stay , leave, top up..
                          0
                          • if you're breakeven, run as fast you can and never look back.
                            3
                        • I am now break even. with the court case like that Shall I leave or stay? Any suggestions would be appreciated..
                          0
                          • When is the 100 eur target?
                            0
                            • 2024
                              0
                            • 3010
                              0
                          • A U.S. judge suggested on Wednesday that Bayer AG include a warning label on Roundup as part of a proposed $2 billion settlement to resolve future claims that the top-selling weedkiller causes cancer.6 hours ago
                            0
                            • I consider this news as positive, but depends on market how it will be handled 😁
                              0
                          • I guess that tomorrow we have rally on BAYGN 😉👍 what so you think?
                            0
                            • new......from CHHABRIA?
                              0
                              • ....continui cosi'e cerchi di arrivare a 100 euro per azione.
                                0
                                • Finalmente laBayer si e'svegliata dal letargo.Forza.
                                  0
                                  • Finally nice move up and lets hope that we move into 60' soon. ;-)
                                    0
                                    • Yess
                                      0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.